Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Faron Pharmaceuticals
Faron Pharmaceuticals
Activities:
Research & Development
X
LinkedIn
Trending Articles
Neopac showcases latest tube, dispensing and cap innovations at Pharmapack Paris
Highlights include company’s reduced material LowPro caps and world’s smallest child resistant tube
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
You need to be a subscriber to read this article.
Click here
to find out more.
Parenteral preparations: formulation challenges
Parenteral preparations are defined as solutions, suspensions, emulsions for injection or infusion, powders for injection or infusion, gels for injection and implants. They are...
Lonza’s capsule delivers acid-sensitive ingredients to the intestine
The capsule can simplify the manufacturing process to accelerate drug development and expedite first-in-human timelines
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Regulatory
New patent protects the intravenous use of interferon-beta in a novel formulation
Faron has developed the first intravenous formulation of IFN-beta to enable the treatment of vascular leakage in lungs and other central organs
Manufacturing
Abzena to manufacture therapeutic antibody for Faron
Clevegen is a novel therapeutic antibody being developed by Faron to reduce immune suppression in cancer
Research & Development
Faron strengthens executive team by appointing new Medical Director
He will play a central role in expanding the Finnish firm's clinical programmes of drug candidates
Research & Development
Faron links up with Selexis to progress development of cancer antibody
Under the agreement, Faron will have access to the Selexis SUREtechnology platform and SURE CHO-M cell line
Ingredients
Rentschler to manufacture Traumakine for Faron
German contract manufacturer first produced product in 1980s
Subscribe now